Emerald Mutual Fund Advisers Trust’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.93M	Sell	329,430 -59,992	-15%	-$898K	0.3%	102
2025 Q1	$6.28M	Buy	389,422 +3,038	+0.8%	+$49K	0.45%	81
2024 Q4	$9M	Buy	386,384 +132,834	+52%	+$3.09M	0.55%	72
2024 Q3	$7.46M	Buy	+253,550	New	+$7.46M	0.39%	85